Is the IQE share price the bargain of the century?

Royston Wild explains why IQE plc (LON: IQE) could provide plenty of upside at current prices.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Excluding a short sharp price spike at the start of the year, the downward shock which struck IQE (LSE: IQE) at the back end of 2017 is showing no signs of letting go just yet.

Market sentiment for the business first soured as short sellers piled in as a response to the AIM company’s stratospheric price rise of recent years (up 672% in the three years to the close of last December). While this is not uncommon for shares whose market values have exploded, reports from sellers like Muddy Waters, which questioned IQE’s accounting procedures, have kept the pressure on.

As if this wasn’t enough, appetite for the stock has been whacked by fears of steeply-declining sales to Apple. Such is the Cupertino company’s dominance that even the faint whiff of falling demand from the world’s most-loved tech manufacturer can break a supplier as quickly and easily as it can make one.

IQE has fallen more than 25% in 2018 alone, closed below the 100p marker in June and is teetering around this level right now. However, I reckon now could be a great time to buy into the stock as I feel investor appetite may be about to turn…

Strong numbers

IQE released a positive set of trading numbers earlier this week when it announced that sales rose to £73m during January-July. It may be only a slight improvement from the revenues of £70m experienced a year earlier, however it wasn’t all that bad when achieved against a currency headwind of 9.5%.

What’s more, and as Barclays Capital was quick to point out, the release showed “the second half ramp for 3D sensing components is strong after the weaker start to the year.” Demand looks set to intensify again after the impact of the destocking of Apple’s iPhone X parts during the early stages of 2018, with three new iPhones with 3D sensing capabilities set to ramp up during the remainder of the year.

Like I said earlier, Apple’s clout has a significant bearing upon the fortunes of those up and down the supply chain. Having said that, the latest release underlined the growing clout that IQE has with other tech mammoths across the globe. Sure, sales may have disappointed in the first half, but “a very significant increase in the number and extent of our engagements with VCSEL chip customers” in the period has taken the edge off, so to speak.

The company is now engaged with 20 VCSEL chip manufacturers spanning Asia, North America and Europe, and capacity expansion at its Newport site in South Wales will give it the manufacturing clout to meet future demand.

Right now IQE deals on a forward P/E ratio of 26.3 times, sailing above the widely-regarded value territory of 15 times or below. That said, I don’t think the tech titan’s valuation is that demanding given that the long-term earnings outlook remains extremely encouraging.

Indeed, after IQE’s predicted earnings rise of 6% in 2018, the business is expected to get back to reporting ripping profits growth with a 36% advance next year. I believe the tech marvel provides plenty of upside risk at current prices and it could prove to be a millionaire-maker in the years to come.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

2 top-notch growth shares I want in my Stocks and Shares ISA in 2026

What do a world-famous tech giant and a fast-growing rocket maker have in common? This writer wants them both in…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

How can we get started building a passive income ISA in 2026?

Didn't an ancient Chinese investor say the journey to a passive income fortune begins with a single step? If they…

Read more »

Investing Articles

Seeking New Year bargains? FTSE 100 index shares remain on sale!

These FTSE 100 index stocks have surged in value in 2026. But they still offer plenty for value investors to…

Read more »

Landlady greets regular at real ale pub
Investing Articles

Will the crashed Diageo share price rebound 63% in 2026?

Diageo's share price has collapsed by more than a third since 1 January. But these brokers expect the FTSE 100…

Read more »

Happy young female stock-picker in a cafe
Investing Articles

1 top investment trust to consider from the FTSE 250 

This niche FTSE 250 investment trust offers exposure to one of Asia's fastest growing economies, potentially setting it up for…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Investing Articles

2 high risk/high reward stock market picks to consider in 2026

The coming year could bring about lots of stock market opportunities for brave investors willing to stomach risk. Mark Hartley…

Read more »

Investing Articles

ChatGPT thinks these are the 5 best FTSE stocks to consider buying for 2026!

Can the AI bot come up trumps when asked to select the best FTSE stocks to buy as we enter…

Read more »

Investing For Beginners

How much do you need in an ISA to make the average UK salary in passive income?

Jon Smith runs through how an ISA can help to yield substantial income for a patient long-term investor, and includes…

Read more »